We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M Turnover 30.23%
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-6.55%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$4.6B
AUM Growth
-$358M
Cap. Flow
+$124M
Cap. Flow %
2.69%
Top 10 Hldgs %
84.57%
Holding
69
New
20
Increased
2
Reduced
18
Closed
6
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.6 years

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$82.3M
2
BABA icon
Alibaba
BABA
+$78.9M
3
RYZB icon
RayzeBio, Inc. Common Stock
RYZB
+$66M
4
DASH icon
DoorDash
DASH
+$52.9M
5
BIDU icon
Baidu
BIDU
+$41M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Healthcare 33.02%
3 Technology 15.02%
4 Real Estate 8.7%
5 Communication Services 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TSM icon
26
TSMC
TSM
$2.15T
$13.3M 0.29%
+98,100
New +$12.2M
2024 Q1
0 quarters
NBP icon
27
NovaBridge Biosciences American Depositary Shares
NBP
$147M
$12.9M 0.28%
6,909,220
– –
2020 Q3
14 quarters
NVDA icon
28
NVIDIA
NVDA
$5.19T
$12.3M 0.27%
+136,000
New +$9.86M
2024 Q1
0 quarters
BABA icon
29
Alibaba
BABA
$272B
$10.4M 0.23%
143,900
-1,076,718
-88% -$78.9M
2022 Q2
7 quarters
SE icon
30
Sea Limited
SE
$57.8B
$9.39M 0.2%
174,800
– –
2023 Q3
2 quarters
APP icon
31
Applovin
APP
$89B
$9.05M 0.2%
+130,800
New +$6.93M
2024 Q1
0 quarters
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.12T
$8.97M 0.19%
+58,900
New +$8.5M
2024 Q1
0 quarters
MU icon
33
Micron Technology
MU
$1T
$8.5M 0.18%
+72,100
New +$6.53M
2024 Q1
0 quarters
MGX icon
34
Metagenomi Therapeutics
MGX
$29.8M
$8.21M 0.18%
+777,768
New +$8.94M
2024 Q1
0 quarters
SOHU icon
35
Sohu.com
SOHU
$331M
$7.54M 0.16%
713,400
-18,400
-3% -$179K
2018 Q4
21 quarters
GOSS icon
36
Gossamer Bio
GOSS
$53.9M
$5.87M 0.13%
62,176
– –
2019 Q1
20 quarters
MRVL icon
37
Marvell Technology
MRVL
$207B
$4.22M 0.09%
+59,500
New +$4.08M
2024 Q1
0 quarters
SGMT icon
38
Sagimet Biosciences
SGMT
$572M
$3.93M 0.09%
724,800
-724,743
-50% -$5.2M
2023 Q3
2 quarters
PACB icon
39
Pacific Biosciences
PACB
$535M
$3.45M 0.07%
918,892
– –
2023 Q3
2 quarters
GE icon
40
GE Aerospace
GE
$326B
$3.3M 0.07%
+23,556
New +$2.78M
2024 Q1
0 quarters
VIPS icon
41
Vipshop
VIPS
$6.13B
$3.29M 0.07%
198,600
– –
2021 Q1
12 quarters
ASML icon
42
ASML
ASML
$634B
$3.2M 0.07%
+3,300
New +$2.93M
2024 Q1
0 quarters
VRT icon
43
Vertiv
VRT
$80B
$3.12M 0.07%
+38,200
New +$2.4M
2024 Q1
0 quarters
META icon
44
Meta Platforms (Facebook)
META
$1.8T
$2.91M 0.06%
+6,000
New +$2.68M
2024 Q1
0 quarters
URA icon
45
Global X Uranium ETF
URA
$4.99B
$2.88M 0.06%
+100,000
New +$2.89M
2024 Q1
0 quarters
AVGO icon
46
Broadcom
AVGO
$1.58T
$2.78M 0.06%
+21,000
New +$2.6M
2024 Q1
0 quarters
TUYA icon
47
Tuya Inc
TUYA
$1.02B
$2.74M 0.06%
1,564,400
-35,300
-2% -$67K
2021 Q1
12 quarters
EM
48
DELISTED
Smart Share Global Ltd
EM
$2.6M 0.06%
3,949,700
– –
2021 Q2
11 quarters
AAPL icon
49
Apple
AAPL
$5T
$2.01M 0.04%
+11,700
New +$2.13M
2024 Q1
0 quarters
BEDU
50
DELISTED
Bright Scholar Education Holdings
BEDU
$1.96M 0.04%
988,143
– –
2018 Q4
21 quarters

Similar funds

HHLR Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, HHLR Advisors held 69 positions worth $4.6B, down 7.2% from $4.96B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

HHLR Advisors's Q1 2024 filing shows 20 new, 2 increased, 18 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 912,400 shares worth $165M. The largest sale was Salesforce, an estimated $82.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.

  • HHLR Advisors's largest Q1 2024 buy was Advanced Micro Devices: 912,400 shares worth $165M.
  • HHLR Advisors added most to Pinduoduo in Q1 2024, an estimated $220M increase.
  • HHLR Advisors's biggest Q1 2024 reduction was Salesforce, cutting an estimated $82.3M.
  • HHLR Advisors fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $66M.
  • HHLR Advisors's ten largest holdings make up 85% of its $4.6B portfolio in Q1 2024.
  • HHLR Advisors opened 20 new positions and closed 6 in Q1 2024.
  • HHLR Advisors's portfolio value fell 7.2% quarter-over-quarter to $4.6B.

Based on HHLR Advisors's 13F filing for Q1 2024, filed 14 May 2024.